AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
-5.57%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$1.45B
AUM Growth
+$1.45B
(-16%)
Cap. Flow
+$42.5M
Cap. Flow
% of AUM
2.93%
Top 10 Holdings %
Top 10 Hldgs %
86.96%
Holding
95
New
13
Increased
7
Reduced
12
Closed
6
Top Buys
| 1 |
Citigroup
C
|
$14.3M |
| 2 |
Dollar General
DG
|
$13.9M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
$12.5M |
| 4 |
Aptiv
APTV
|
$10.2M |
| 5 |
BRF SA
BRFS
|
$8.93M |
Top Sells
| 1 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$13.3M |
| 2 |
Goldman Sachs
GS
|
$8.86M |
| 3 |
Crown Castle
CCI
|
$7.34M |
| 4 |
FURX
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
|
$6.26M |
| 5 |
IMGN
Immunogen Inc
IMGN
|
$5.23M |
Sector Composition
| 1 | Consumer Discretionary | 43.08% |
| 2 | Healthcare | 42.16% |
| 3 | Consumer Staples | 2.43% |
| 4 | Financials | 1.34% |
| 5 | Real Estate | 0.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WW
1
DELISTED
WW International
WW
| $591M | 21.38% | 28,749,089 | – | – |
|
2
Lexicon Pharmaceuticals
LXRX
$400M
| $438M | 15.87% | 253,372,135 | – | – |
|
|
FURX
3
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
| $69.5M | 2.52% | 798,900 -71,942 | -8% | -$6.26M |
|
|
AUXL
4
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $37.4M | 1.35% | 1,375,000 -125,000 | -8% | -$3.4M |
|
5
BioMarin Pharmaceuticals
BMRN
$11.2B
| $35.8M | 1.3% | 525,000 +125,000 | +31% | +$8.53M |
|
|
PCYC
6
DELISTED
PHARMACYCLICS INC
PCYC
| $21M | 0.76% | 210,000 +45,000 | +27% | +$4.51M |
|
|
IMGN
7
DELISTED
Immunogen Inc
IMGN
| $19.4M | 0.7% | 1,300,000 -350,000 | -21% | -$5.23M |
|
8
Amgen
AMGN
$155B
| $18.5M | 0.67% | 150,000 | – | – |
|
9
Nektar Therapeutics
NKTR
$568M
| $15.8M | 0.57% | 1,300,000 -300,000 | -19% | -$3.64M |
|
|
10
Citigroup
C
$178B
| $14.3M | 0.52% | +300,000 | New | +$14.3M |
|
|
ARRY
11
DELISTED
Array Biopharma Inc
ARRY
| $14.1M | 0.51% | 3,000,000 | – | – |
|
|
12
Dollar General
DG
$23.9B
| $13.9M | 0.5% | +250,000 | New | +$13.9M |
|
13
Alnylam Pharmaceuticals
ALNY
$58.5B
| $13.8M | 0.5% | 205,000 +80,000 | +64% | +$5.37M |
|
|
ACOR
14
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $13.3M | 0.48% | 350,000 -350,000 | -50% | -$13.3M |
|
|
MJN
15
DELISTED
Mead Johnson Nutrition Company
MJN
| $12.5M | 0.45% | +150,000 | New | +$12.5M |
|
16
General Motors
GM
$55.8B
| $12M | 0.44% | 350,000 +100,000 | +40% | +$3.44M |
|
|
17
Aptiv
APTV
$17.3B
| $10.2M | 0.37% | +150,000 | New | +$10.2M |
|
|
18
BRF SA
BRFS
$6.12B
| $8.93M | 0.32% | +446,900 | New | +$8.93M |
|
19
Ralph Lauren
RL
$18B
| $8.05M | 0.29% | +50,000 | New | +$8.05M |
|
|
CERE
20
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
| $7.21M | 0.26% | 8,192,167 +4,000,000 | +95% | +$3.52M |
|
21
Anywhere Real Estate
HOUS
$684M
| $6.52M | 0.24% | 150,000 -25,000 | -14% | -$1.09M |
|
22
Incyte
INCY
$16.5B
| $5.35M | 0.19% | +100,000 | New | +$5.35M |
|
23
Xoma
XOMA
$392M
| $5.21M | 0.19% | 1,000,000 -1,000,000 | -50% | -$5.21M |
|
24
MGIC Investment
MTG
$6.42B
| $5.11M | 0.19% | 600,000 +100,000 | +20% | +$852K |
|
|
MRTX
25
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $4.77M | 0.17% | 250,000 +75,000 | +43% | +$1.43M |
|